News
Novo Nordisk partners OpenAI on R&D "transformation"
Seeking an R&D edge, Novo Nordisk has become the latest big pharma group to forge an alliance with tech giant OpenAI.
News
Travere claims first FDA OK in rare kidney disease FSGS
Shrugging off an earlier phase 3 disappointment, Travere’s Filspari has become the first FDA-approved treatment for rare kidney disease FSGS.
Sales & Marketing
The UK’s medicine supply is about to be tested and pharmacie...
The current disruption shows supply chains are not abstract systems, but physical networks, dependent on specific routes, materials & decisions.
News
FDA hands another rejection to Replimune's melanoma therapy
Replimune has had its advanced melanoma treatment RP1 turned down by the FDA for a second time, prompting job losses.
News
Senju launches first-in-class dry eye disease drug in Japan
Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
